These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18241255)

  • 21. Primary acquired sideroblastic anaemia and myeloproliferative disease: a report on three cases.
    Williams MD; Shinton NK; Finney RD
    Clin Lab Haematol; 1985; 7(2):113-8. PubMed ID: 4042563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Platelet indices: evaluation and clinical significance].
    Fernández de Castro M; Viloria A; Larrocha C; Latorre P; Tafalla C; Jiménez MC
    Sangre (Barc); 1987; 32(6):735-42. PubMed ID: 3438812
    [No Abstract]   [Full Text] [Related]  

  • 23. Is International Prognostic Scoring System (IPSS) still standard in predicting prognosis in patients with myelodysplastic syndrome? External validation of the WHO Classification-Based Prognostic Scoring System (WPSS) and comparison with IPSS.
    Park MJ; Kim HJ; Kim SH; Kim DH; Kim SJ; Jang JH; Kim K; Kim WS; Jung CW
    Eur J Haematol; 2008 Nov; 81(5):364-73. PubMed ID: 18637029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet morphology, platelet mass, platelet count and prognosis in patients with myelodysplastic syndromes.
    Germing U; Platzbecker U; Giagounidis A; Aul C
    Br J Haematol; 2007 Aug; 138(3):399-400. PubMed ID: 17555472
    [No Abstract]   [Full Text] [Related]  

  • 25. Analysis of prognostic factors in patients with refractory anemia with excess of blasts (RAEB) reclassified according to WHO proposal.
    Breccia M; Latagliata R; Cannella L; Carmosino I; De Cuia R; Frustaci A; Stefanizzi C; Santopietro M; Alimena G
    Leuk Res; 2009 Mar; 33(3):391-4. PubMed ID: 18676015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [4 cases of refractory sideroblastic anemia].
    Lavrova OP; Amirkhanian ES; Fetisov VV; Soboleva IuG; Susoeva VM
    Probl Gematol Pereliv Krovi; 1973 Mar; 18(3):50-5. PubMed ID: 4768280
    [No Abstract]   [Full Text] [Related]  

  • 27. Leukocyte abnormalities in idiopathic refractory sideroblastic anemia: an indolent myeloproliferative disease.
    Hooper AD
    J Am Osteopath Assoc; 1981 Jun; 80(10):671-8. PubMed ID: 7239958
    [No Abstract]   [Full Text] [Related]  

  • 28. Idiopathic refractory sideroblastic anemia: incidence and risk factors for leukemic transformation.
    Cheng DS; Kushner JP; Wintrobe MM
    Cancer; 1979 Aug; 44(2):724-31. PubMed ID: 383260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count.
    Perosa F; Minoia C; Favoino E; Prete M; Dammacco F
    Blood Cells Mol Dis; 2009; 42(1):71-6. PubMed ID: 18996035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular events and risk factors for thrombosis in refractory anemia with ring sideroblasts and thrombocytosis.
    Patnaik MM; Lasho TL; Finke CM; Hanson CA; King RL; Ketterling RP; Gangat N; Tefferi A
    Leukemia; 2016 Nov; 30(11):2273-2275. PubMed ID: 27479179
    [No Abstract]   [Full Text] [Related]  

  • 31. Usefulness of immature platelet fraction for the clinical evaluation of myelodysplastic syndromes.
    Saigo K; Takenokuchi M; Imai J; Numata K; Isono S; Zenibayashi M; Tanioka H; Yoshioka T; Nishizawa A; Takada M; Nomura T; Kubota Y
    Lab Hematol; 2009; 15(2):13-6. PubMed ID: 19561008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Case of primary acquired sideroblastic anemia--with special reference to functional examinations of granulocytes, lymphocytes and platelets].
    Fujii M; Oshiro I; Nakamine H; Takenaka T; Maeda J; Tsukiyama K; Inui J
    Rinsho Ketsueki; 1983 Feb; 24(2):197-205. PubMed ID: 6655879
    [No Abstract]   [Full Text] [Related]  

  • 33. Aberrant increase in the immature platelet fraction in patients with myelodysplastic syndrome: a marker of karyotypic abnormalities associated with poor prognosis.
    Sugimori N; Kondo Y; Shibayama M; Omote M; Takami A; Sugimori C; Ishiyama K; Yamazaki H; Nakao S
    Eur J Haematol; 2009 Jan; 82(1):54-60. PubMed ID: 18801060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
    Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet dysfunction in preleukemic states and in various types of leukemia.
    Sultan Y; Caen JP
    Ann N Y Acad Sci; 1972 Oct; 201():300-6. PubMed ID: 4509686
    [No Abstract]   [Full Text] [Related]  

  • 36. Sideroblastic anaemia progressing to preleukaemia.
    Gupta A; Rao PV
    J Assoc Physicians India; 1984 Nov; 32(11):998-1000. PubMed ID: 6526791
    [No Abstract]   [Full Text] [Related]  

  • 37. Immature platelet fraction as novel laboratory parameter predicting the course of neonatal thrombocytopenia.
    Cremer M; Paetzold J; Schmalisch G; Hammer H; Loui A; Dame C; Weimann A
    Br J Haematol; 2009 Feb; 144(4):619-21. PubMed ID: 19036085
    [No Abstract]   [Full Text] [Related]  

  • 38. Growth differentiation factor 15 production is necessary for normal erythroid differentiation and is increased in refractory anaemia with ring-sideroblasts.
    Ramirez JM; Schaad O; Durual S; Cossali D; Docquier M; Beris P; Descombes P; Matthes T
    Br J Haematol; 2009 Jan; 144(2):251-62. PubMed ID: 19036111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New prognostic index to predict survival in patients with cancer of unknown primary site with unfavourable prognosis.
    Trivanović D; Petkovic M; Stimac D
    Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):43-8. PubMed ID: 18976894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor patients.
    Song Z; Wang JL; Pan YL; Tao DY; Gan MF; Huang KE
    Hepatogastroenterology; 2009; 56(89):149-53. PubMed ID: 19453047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.